Oncology & Cancer

Study identifies cancer patients most likely to develop cachexia

It is estimated that as many as 80% of advanced-stage cancer patients may develop cachexia, a potentially fatal metabolic syndrome characterized by extreme weight loss and muscle wasting, but scientists do not yet fully understand ...

Oncology & Cancer

MRI frequently underestimates tumor size in prostate cancer

A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that magnetic resonance imaging, or MRI, frequently underestimates the size of prostate tumors, potentially leading to undertreatment.

Oncology & Cancer

New technique improves T cell-based immunotherapies for solid tumors

Scientists from Scripps Research have enhanced an existing immunotherapy by removing the sugar coating surrounding solid tumors—such as in melanoma, breast, and prostate cancer—so T cells can more effectively kill tumor ...

page 21 from 40